295 related articles for article (PubMed ID: 23987999)
21. Alirocumab as add-on therapy to statins: current evidence and clinical potential.
Auer J; Berent R
Ther Adv Cardiovasc Dis; 2018 Jul; 12(7):191-202. PubMed ID: 29792380
[TBL] [Abstract][Full Text] [Related]
22. An emerging role for Serine Protease Inhibitors in T lymphocyte immunity and beyond.
Ashton-Rickardt PG
Immunol Lett; 2013 Apr; 152(1):65-76. PubMed ID: 23624075
[TBL] [Abstract][Full Text] [Related]
23. Serpins and regulation of cell death.
Bird PI
Results Probl Cell Differ; 1998; 24():63-89. PubMed ID: 9949832
[TBL] [Abstract][Full Text] [Related]
24. Novel perspectives in clinical cardiology and cardiac surgery.
Mihailidou AS
Future Cardiol; 2014 Nov; 10(6):677-8. PubMed ID: 25495807
[TBL] [Abstract][Full Text] [Related]
25. Anti-atherothrombogenic properties of PEDF.
Yamagishi SI; Matsui T
Curr Mol Med; 2010 Apr; 10(3):284-91. PubMed ID: 20236055
[TBL] [Abstract][Full Text] [Related]
26. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
Front Immunol; 2018; 9():706. PubMed ID: 29719532
[TBL] [Abstract][Full Text] [Related]
27. Small-molecule modulators of serine protease inhibitor proteins (serpins).
Kellici TF; Pilka ES; Bodkin MJ
Drug Discov Today; 2021 Feb; 26(2):442-454. PubMed ID: 33259801
[TBL] [Abstract][Full Text] [Related]
28. [Management of hypercholesterolemia in patients with acute coronary syndrome: current mechanisms and future perspectives].
Lettino M
G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):31S-7. PubMed ID: 27312021
[TBL] [Abstract][Full Text] [Related]
29. [Serine protease inhibitors (serpins); regulators of coagulation and inflammation reactions with therapeutic potential].
Hack CE; Abbink JJ; Nuijens JH
Ned Tijdschr Geneeskd; 1990 May; 134(21):1035-9. PubMed ID: 2195358
[No Abstract] [Full Text] [Related]
30. Serpins: Development for Therapeutic Applications.
Lucas A; Yaron JR; Zhang L; Macaulay C; McFadden G
Methods Mol Biol; 2018; 1826():255-265. PubMed ID: 30194606
[TBL] [Abstract][Full Text] [Related]
31. Serine protease inhibitors and cytotoxic T lymphocytes.
Ashton-Rickardt PG
Immunol Rev; 2010 May; 235(1):147-58. PubMed ID: 20536561
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in Understanding the Pathogenesis of Cardiovascular Diseases and Development of Treatment Modalities.
Mittal R; Jhaveri VM; Kay SS; Greer A; Sutherland KJ; McMurry HS; Lin N; Mittal J; Malhotra AK; Patel AP
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):19-32. PubMed ID: 29737266
[TBL] [Abstract][Full Text] [Related]
33. Can a viral serine proteinase inhibitor prevent postangioplasty restenosis?
Haber E
Circulation; 1996 Dec; 94(11):2694-5. PubMed ID: 8941089
[No Abstract] [Full Text] [Related]
34. Vascular proteomics.
Barderas MG; Vivanco F; Alvarez-Llamas G
Methods Mol Biol; 2013; 1000():1-20. PubMed ID: 23585080
[TBL] [Abstract][Full Text] [Related]
35. The F-helix of serpins plays an essential, active role in the proteinase inhibition mechanism.
Gettins PG
FEBS Lett; 2002 Jul; 523(1-3):2-6. PubMed ID: 12123794
[TBL] [Abstract][Full Text] [Related]
36. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles.
Janciauskiene S
Biochim Biophys Acta; 2001 Mar; 1535(3):221-35. PubMed ID: 11278163
[TBL] [Abstract][Full Text] [Related]
37. [Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure].
Tokgözoğlu L
Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():11-6. PubMed ID: 19404045
[TBL] [Abstract][Full Text] [Related]
38. The role of apoptotic cell death in cardiovascular disease.
McLaughlin R; Kelly CJ; Kay E; Bouchier-Hayes D
Ir J Med Sci; 2001; 170(2):132-40. PubMed ID: 11491050
[TBL] [Abstract][Full Text] [Related]
39. Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes.
Liberale L; Montecucco F; Camici GG; Dallegri F; Vecchie A; Carbone F; Bonaventura A
Curr Med Chem; 2017; 24(14):1403-1416. PubMed ID: 28260498
[TBL] [Abstract][Full Text] [Related]
40. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
